COMPANY NAME INDICATION DEVELOPMENT PHASE AVAILABLE TECHNOLOGY TRANSFER
IN PROGRESS
PATENT PRODUCT
Biotechnology Assets Fermentation-based ingredients Development and industrial scale-up supply of fermentation-based ingredients with applications in food and fragrancies markets. From lab to industrial scale up to 225 m3 tanks. GMP, Halal, and Kosher certification 3RFE Fermentation-based ingredients
Celavista Mito-Biogénesis NMX-FixCo2 (Bioprocess & Bioproducts) New technology, products and processes for the regulation of CO2: capture, fixation and indication; with industrial, agricultural and non-industrial uses more efficient than other processes; from organic waste products 1BR&D NMX-FixCo2 (Bioprocess & Bioproducts)
FUNDACIÓN CENER-CIEMAT BIOBASED PRODUCTS DEVELOPMENT IN THE CENER BIO2C R&D services and technical assistance to all agents of the sector. Development and upscalling from lab to demo escale. https://www.bio2c.es/biochemical-unit/ 3RFE BIOBASED PRODUCTS DEVELOPMENT IN THE CENER BIO2C
Institut Quimic de Sarrià (IQS) Fermentation Pilot Plant Bioprocess development and optimization. From Lab to pre-industrial scale. Upstream and downstream. 3RFE Fermentation Pilot Plant
IRIAF-CLAMBER Fermentation train Scale up of any fermentation, from scale lab to a possible 20m3 reactor. Upstream and downstream possible optimization. 3RFE Fermentation train
Leitat Environmental microbiome assessment Environmental microbiome characterization (soil, air, water): biodiversity studies applying -omic techniques and determining possible correlation with other parameters (contamination, disinfection or remediation techniques, exposition to toxic compounds, 3RFE Environmental microbiome assessment
Leitat Fermentation process using extremophile strains Optimization of culture media and process parameters for enhancing bioproduct production using halophile strains. Up to 5L 3RFE Fermentation process using extremophile strains
VIVEBIOTECH Bioprocess development and GMP manufacturing of lentiviral vectors Wide range of indications, ranging from rare/ultrarare diseases to immune-cell therapy projects for cancer i.e. CAR-Ts... as well as for making vaccines. VIVEbiotech can manufacture lentiviral vectors for both ex-vivo and in-vivo use. 3RFE Bioprocess development and GMP manufacturing of lentiviral vectors